Home » Human Growth Hormone Clinical Trials

Human Growth Hormone Clinical Trials

Bookmarkx

Human Growth Hormone Benefits

Growth Hormone Replacement Therapy has enormous benefits for men experiencing symptoms due to andropause (male menopause) and women experiencing pre-menopause and menopause. Learn about HGH Therapy with Bio-Identical Injectable Growth Hormone and Bio-Identical Hormone Replacement Therapy (BHRT) at the Anti-Aging Medical Group, Age Management Medicine Physicians specializing in Hormone Optimization.


To learn more about HGH, low growth hormone symptoms, HGH treatment and bio-identical growth hormone therapy to increase HGH levels with hormone replacement injections, visit Human Growth Hormone Therapy & HGH Injection Treatments


Human Growth Hormone Clinical Trials

The following listings come from a database of more than 41,000 active industry and government-sponsored HGH and hormone clinical trials. This includes new hormone drug therapies in research and hormone therapy drugs recently approved by the FDA.

Human Growth Hormone Clinical Trials

1. Newly Approved Drug Therapies (824): Somavert (pegvisomant)
Somavert (pegvisomant), an analog of human growth hormone, is an injectable medication
that has been structurally altered to act as a growth hormone (GH
2. Newly Approved Drug Therapies (152): Humatrope (somatropin [rDNA
Humatrope is a synthetic human growth hormone (gGH) that has been used since 1987
as a replacement therapy for children who do not produce enough or any of
3. Newly Approved Drug Therapies (712): Genotropin (somatropin)
vitro, preclinical and clinical tests have demonstrated that Genotropin Lyophilized
Powder is therapeutically equivalent to human growth hormone of pituitary
4. Newly Approved Drug Therapies (236): Norditropin (somatropin (rDNA …
Human growth hormone is responsible for stimulating normal skeletal, connective
tissue, muscle and organ growth in children and adolescents.
5. Newly Approved Drug Therapies (335): Genotropin Lyophilized Powder .
In vitro, preclinical, and clinical studies have demonstrated that Genotropin is
therapeutically equivalent to human growth hormone of pituitary origin.
6. MPIP – Clinical Trials Resource Center
Human growth hormone is responsible for stimulating normal skeletal, connective
tissue, muscle and organ growth in children and adolescents.
7. Drugs Approved by the FDA
Somavert (pegvisomant), an analog of human growth hormone, is an injectable medication
that has been structurally altered to act as a growth hormone (GH
8. MPIP – Clinical Trials Resource Center
vitro, preclinical and clinical tests have demonstrated that Genotropin Lyophilized
Powder is therapeuticallvitro, preclinical and clinical tests have demonstrated that Genotropin Lyophilized
Powder is therapeutically equivalent to human growth hormone of pituitary y equivalent to human growth hormone of pituitary
9. MPIP – Clinical Trials Resource Center
In vitro, preclinical, and clinical studies have demonstrated that Genotropin is
therapeutically equivalent to human growth hormone of pituitary origin.
10. Drugs Approved by the FDA
Human growth hormone is responsible for stimulating normal skeletal, connective
tissue, muscle and organ growth in children and adolescents.
11.
Centerwatch:
Powder is therapeutically equivalent to human growth hormone of pituitary
origin and achieves similar pharmacokinetic profiles in normal adults
12.
Drugs Approved by the FDA
In vitro, preclinical, and clinical studies have demonstrated that Genotropin
is therapeutically equivalent to human growth hormone of pituitary origin.
13.
CenterWatch Clinical Research Center Profile (2222): Infectious
A randomised, parallel group, double-blind, placebo controlled, dose-ranging
multicentre study of recombinant human growth hormone in the treatment of
14.
Drugs Approved by the FDA:
Humatrope is a synthetic human growth hormone (gGH) that has been used since
1987 as a replacement therapy for children who do not produce enough or any
15.
Centerwatch:
In vitro, preclinical, and clinical studies have demonstrated that Genotropin
is therapeutically equivalent to human growth hormone of pituitary origin.
16.
Centerwatch
Human growth hormone is responsible for stimulating normal skeletal, connective
tissue, muscle and organ growth in children and adolescents.

 

17.
Clinical Trials Resource Center
Somavert (pegvisomant), an analog of human growth hormone, is an injectable
medication that has been structurally altered to act as a growth hormone
18.
Centerwatch:
Humatrope is a synthetic human growth hormone (gGH) that has been used since
1987 as a replacement therapy for children who do not produce enough or any
19.
An online Healthcare and Medical Information Portal – Directory …:
Somavert (pegvisomant), an analog of human growth hormone, is an injectable medication
that has been structurally altered to act as a growth hormone (GH
20.
Centerwatch
Human growth hormone is responsible for stimulating normal skeletal, connective
tissue, muscle and organ growth in children and adolescents.
21.
The American Pain Foundation
vitro, preclinical and clinical tests have demonstrated that Genotropin Lyophilized
Powder is therapeutically equivalent to human growth hormone of pituitary
22.
Clinical Trials Resource Center
Somavert (pegvisomant), an analog of human growth hormone, is an injectable medication
that has been structurally altered to act as a growth hormone (GH
23.
Clinical Trials Resource Center
vitro, preclinical and clinical tests have demonstrated that Genotropin Lyophilized
Powder is therapeutically equivalent to human growth hormone of pituitary
24.
Centerwatch
Humatrope is a synthetic human growth hormone (gGH) that has been used since 1987
as a replacement therapy for children who do not produce enough or any of
25.
The American Pain Foundation:
Human growth hormone is responsible for stimulating normal skeletal, connective
tissue, muscle and organ growth in children and adolescents.
26.
Clinical Trials Resource Center
Human growth hormone is responsible for stimulating normal skeletal, connective
tissue, muscle and organ growth in children and adolescents.
27.
An online Healthcare and Medical Information Portal – Directory
Somavert (pegvisomant), an analog of human growth hormone, is an injectable medication
that has been structurally altered to act as a growth hormone (GH
28.
Resources – The Breast Cancer Fund
Somavert (pegvisomant), an analog of human growth hormone, is an injectable medication
that has been structurally altered to act as a growth hormone (GH
29.
AAFA Home Page:
Somavert (pegvisomant), an analog of human growth hormone, is an injectable medication
that has been structurally altered to act as a growth hormone (GH